Kuang-tai Kuo

查看斯高帕斯 (Scopus) 概要

電子郵件ktkuotmu.edutw

h-index

每年研究成果

學歷

2005-2011 陽明大學臨床醫學研究所博士
1990-1997 國立臺灣大學醫學士

經歷

2025.08- 臺北醫學大學臺北癌症中心食道癌團隊召集人
2024.07-2024.08 衛生福利部雙和醫院外科小兒外科部代主任
2024.02- 臺北醫學大學醫學系外科學科主任
2022.12-2024.10 衛生福利部雙和醫院外科部心臟外科主任
2022.08- 臺北醫學大學醫學系外科學科教授
2022.08- 臺北醫學大學器官移植研究中心副主任
2021.11-2025.07 衛生福利部雙和醫院外科部主任
2020.03- 臺北醫學大學醫學系外科學科胸腔外科主任
2019.02-2022.07 臺北醫學大學醫學系外科學科副教授
衛生福利部雙和醫院外科胸腔外科主任
衛生福利部雙和醫院主治醫師
2014 京都大學附屬醫院訪問學者
2013 杜克大學醫學中心訪問學者
2012.11- 2019.01 臺北醫學大學醫學系外科學科助理教授
2004.11-2010.05 慈濟台北分院主治醫師
2003.10-2004.09 羅東博愛醫院主治醫師
1999.07-2003.09 台北榮總住院醫師
1998.07-1999.06 林口長庚醫院住院醫師
1997.07-1998.06 署立台北醫院住院醫師

獎項

2014-2016 國科會專題計畫補助
2012-2013 國科會專題計畫補助
2008-2009 國科會專題計畫補助
2006-2007 國科會專題計畫補助

研究興趣

胸腔外科
腫瘤外科
肺臟移植
分子生物學
腫瘤轉移

指紋

查看啟用 Kuang-tai Kuo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

1 類似的個人檔案

2 使用中
10 已完成

標靶EYA2-TEAD4-OMA1訊號軸調控粒線體活性以克服頑固型耐藥休眠肺癌細胞的治療抗性(3/3)
Kuo, K.-T. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
標靶EYA2-TEAD4-OMA1訊號軸調控粒線體活性以克服頑固型耐藥休眠肺癌細胞的治療抗性
Kuo, K.-T. (PI)
8/1/23 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
標靶EYA2-TEAD4-OMA1訊號軸調控粒線體活性以克服頑固型耐藥休眠肺癌細胞的治療抗性(2/3)
Kuo, K.-T. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
開發治療非小細胞肺癌藥物的新策略：針對頑固型耐藥休眠細胞內EYA2/ BRD4訊號軸標靶療法
Kuo, K.-T. (PI)
8/1/22 → 7/31/23
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
將BTK-ITK途徑作為標靶以克服肺癌治療的抗藥性以及抑制腦轉移的策略(3/3)
Kuo, K.-T. (PI)
8/1/21 → 7/31/22
研究計畫: A - 政府部門 › b - 國家科學及技術委員會

Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities
Ling, H. H., Huang, H. Y., Huang, C. M., Yasir, M., Ko, C. C., Yadav, V. K., Kuo, K. T., Yeh, C. T. & Tsai, J. T., 1月 2026, 於: Translational Oncology. 63, 102579.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
NMN-primed exosomes derived from infrapatellar fat pad mesenchymal stem cells exert synergistic anti-inflammatory and cartilage-protective effects via MERTK pathway activation in knee osteoarthritis
Chen, K. T., Huang, C. C., Yadav, V. K., Pikatan, N. W., Fong, I. H., Kuo, K. T. & Chiu, Y. S., 1月 5 2026, 於: International Journal of Pharmaceutics. 687, 126367.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Targeting PPP1R15B and ATF4 axis in hepatocellular carcinoma: A novel strategy for overcoming lenvatinib-tolerant persister cells through GPX4-mediated ferroptosis induction
Chen, M. Y., Lai, S. W., Cheng, Y. C., Yadav, V. K., Fong, I. H., Kuo, K. T., Lee, K. H. & Cherng, Y. G., 3月 1 2026, 於: European Journal of Pharmaceutical Sciences. 218, 107434.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells
Lai, S. W., Cheng, Y. C., Hsieh, M. S., Kuo, K. T., Yadav, V. K., Tzeng, Y. M., Yeh, C. T. & Tsai, T. Y., 11月 5 2025, 於: European Journal of Pharmacology. 1006, 178115.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
Correction: 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression (Cancers, (2018), 10, 8, (269), 10.3390/cancers10080269)
Bamodu, O. A., Yang, C. K., Cheng, W. H., Tzeng, D. T. W., Kuo, K. T., Huang, C. C., Deng, L., Hsiao, M., Lee, W. H. & Yeh, C. T., 10月 2025, 於: Cancers. 17, 20, 3304.
研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

Additional file 3: of Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K.-T. (Contributor), Huang, W.-C. (Contributor), Bamodu, O. (Contributor), Lee, W.-H. (Contributor), Wang, C.-H. (Contributor), Hsiao, M. (Contributor), Wang, L.-S. (Contributor) & Yeh, C.-T. (Contributor), Unknown Publisher, 8月 9 2018
DOI: 10.6084/m9.figshare.6953543.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/6953543/1
資料集: Dataset
Additional file 3: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
Huang, W.-C. (Contributor), Kuo, K.-T. (Contributor), Wang, C.-H. (Contributor), Yeh, C.-T. (Contributor) & Wang, Y. (Contributor), Unknown Publisher, 1月 1 2019
DOI: 10.6084/m9.figshare.8057546.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Cisplatin_resistant_lung_cancer_cells_promoted_M2_polarization_of_tumor-associated_macrophages_via_the_Src_CD155_MIF_functional_pathway/8057546/1
資料集: Dataset
Additional file 2: of Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K.-T. (Contributor), Huang, W.-C. (Contributor), Bamodu, O. (Contributor), Lee, W.-H. (Contributor), Wang, C.-H. (Contributor), Hsiao, M. (Contributor), Wang, L.-S. (Contributor) & Yeh, C.-T. (Contributor), Unknown Publisher, 8月 9 2018
DOI: 10.6084/m9.figshare.6953528.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/6953528/1
資料集: Dataset
Additional file 1: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
Huang, W.-C. (Contributor), Kuo, K.-T. (Contributor), Wang, C.-H. (Contributor), Yeh, C.-T. (Contributor) & Wang, Y. (Contributor), Unknown Publisher, 1月 1 2019
DOI: 10.6084/m9.figshare.8057528.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Cisplatin_resistant_lung_cancer_cells_promoted_M2_polarization_of_tumor-associated_macrophages_via_the_Src_CD155_MIF_functional_pathway/8057528/1
資料集: Dataset
Additional file 2: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
Huang, W.-C. (Contributor), Kuo, K.-T. (Contributor), Wang, C.-H. (Contributor), Yeh, C.-T. (Contributor) & Wang, Y. (Contributor), Unknown Publisher, 1月 1 2019
DOI: 10.6084/m9.figshare.8057534.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Cisplatin_resistant_lung_cancer_cells_promoted_M2_polarization_of_tumor-associated_macrophages_via_the_Src_CD155_MIF_functional_pathway/8057534/1
資料集: Dataset

郭光泰

個人檔案

學歷

經歷

獎項

研究興趣

指紋

過去五年中的合作和熱門研究領域

深入探索詳細資料

標靶EYA2-TEAD4-OMA1訊號軸調控粒線體活性以克服頑固型耐藥休眠肺癌細胞的治療抗性(3/3)

標靶EYA2-TEAD4-OMA1訊號軸調控粒線體活性以克服頑固型耐藥休眠肺癌細胞的治療抗性

標靶EYA2-TEAD4-OMA1訊號軸調控粒線體活性以克服頑固型耐藥休眠肺癌細胞的治療抗性(2/3)

開發治療非小細胞肺癌藥物的新策略：針對頑固型耐藥休眠細胞內EYA2/ BRD4訊號軸標靶療法

將BTK-ITK途徑作為標靶以克服肺癌治療的抗藥性以及抑制腦轉移的策略(3/3)

Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities

NMN-primed exosomes derived from infrapatellar fat pad mesenchymal stem cells exert synergistic anti-inflammatory and cartilage-protective effects via MERTK pathway activation in knee osteoarthritis

Targeting PPP1R15B and ATF4 axis in hepatocellular carcinoma: A novel strategy for overcoming lenvatinib-tolerant persister cells through GPX4-mediated ferroptosis induction

Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells

Correction: 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression (Cancers, (2018), 10, 8, (269), 10.3390/cancers10080269)

Additional file 3: of Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor

Additional file 3: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway

Additional file 2: of Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor

Additional file 1: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway

Additional file 2: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway

郭 光泰

個人檔案

學歷

經歷

獎項

研究興趣

指紋

過去五年中的合作和熱門研究領域

專案

研究成果

資料集

郭光泰